Efficacy and safety of lubiprostone for the treatment of functional constipation in Chinese adult patients: A multicenter, randomized, double‐blind, placebo‐controlled trial

Volume: 22, Issue: 11, Pages: 622 - 629
Published: Nov 1, 2021
Abstract
Objectives Functional constipation is a gastrointestinal disorder prevalent around the world. Lubiprostone is the first locally acting type‐2 chloride channel activator to be used for treating constipation. This study aimed to evaluate the efficacy and safety of lubiprostone in Chinese adults with functional constipation. Methods This was a multicenter, randomized, double‐blind, placebo‐controlled study. Patients with functional constipation...
Paper Details
Title
Efficacy and safety of lubiprostone for the treatment of functional constipation in Chinese adult patients: A multicenter, randomized, double‐blind, placebo‐controlled trial
Published Date
Nov 1, 2021
Volume
22
Issue
11
Pages
622 - 629
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.